Cargando…

Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease

BACKGROUND: Crohn’s disease is a lifelong disease characterized by chronic inflammation of the gastrointestinal tract. Defining the cellular and transcriptional composition of the mucosa at different stages of disease progression is needed for personalized therapy in Crohn’s. METHODS: Ileal biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddipatla, Sushma Chowdary, Kolachala, Vasantha L, Venkateswaran, Suresh, Dodd, Anne F, Pelia, Ranjit Singh, Geem, Duke, Yin, Hong, Sun, Yutong, Xu, Congmin, Mo, Angela, Kosters, Astrid, Yang, Junkai, Matthews, Jason D, Ghosn, Eliver, Kugathasan, Subra, Qiu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890215/
https://www.ncbi.nlm.nih.gov/pubmed/36206201
http://dx.doi.org/10.1093/ibd/izac201
_version_ 1784880904564375552
author Maddipatla, Sushma Chowdary
Kolachala, Vasantha L
Venkateswaran, Suresh
Dodd, Anne F
Pelia, Ranjit Singh
Geem, Duke
Yin, Hong
Sun, Yutong
Xu, Congmin
Mo, Angela
Kosters, Astrid
Yang, Junkai
Matthews, Jason D
Ghosn, Eliver
Kugathasan, Subra
Qiu, Peng
author_facet Maddipatla, Sushma Chowdary
Kolachala, Vasantha L
Venkateswaran, Suresh
Dodd, Anne F
Pelia, Ranjit Singh
Geem, Duke
Yin, Hong
Sun, Yutong
Xu, Congmin
Mo, Angela
Kosters, Astrid
Yang, Junkai
Matthews, Jason D
Ghosn, Eliver
Kugathasan, Subra
Qiu, Peng
author_sort Maddipatla, Sushma Chowdary
collection PubMed
description BACKGROUND: Crohn’s disease is a lifelong disease characterized by chronic inflammation of the gastrointestinal tract. Defining the cellular and transcriptional composition of the mucosa at different stages of disease progression is needed for personalized therapy in Crohn’s. METHODS: Ileal biopsies were obtained from (1) control subjects (n = 6), (2) treatment-naïve patients (n = 7), and (3) established (n = 14) Crohn’s patients along with remission (n = 3) and refractory (n = 11) treatment groups. The biopsies processed using 10x Genomics single cell 5' yielded 139 906 cells. Gene expression count matrices of all samples were analyzed by reciprocal principal component integration, followed by clustering analysis. Manual annotations of the clusters were performed using canonical gene markers. Cell type proportions, differential expression analysis, and gene ontology enrichment were carried out for each cell type. RESULTS: We identified 3 cellular compartments with 9 epithelial, 1 stromal, and 5 immune cell subtypes. We observed differences in the cellular composition between control, treatment-naïve, and established groups, with the significant changes in the epithelial subtypes of the treatment-naïve patients, including microfold, tuft, goblet, enterocyte,s and BEST4+ cells. Surprisingly, fewer changes in the composition of the immune compartment were observed; however, gene expression in the epithelial and immune compartment was different between Crohn’s phenotypes, indicating changes in cellular activity. CONCLUSIONS: Our study identified cellular and transcriptional signatures associated with treatment-naïve Crohn’s disease that collectively point to dysfunction of the intestinal barrier with an increase in inflammatory cellular activity. Our analysis also highlights the heterogeneity among patients within the same disease phenotype, shining a new light on personalized treatment responses and strategies.
format Online
Article
Text
id pubmed-9890215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98902152023-02-02 Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease Maddipatla, Sushma Chowdary Kolachala, Vasantha L Venkateswaran, Suresh Dodd, Anne F Pelia, Ranjit Singh Geem, Duke Yin, Hong Sun, Yutong Xu, Congmin Mo, Angela Kosters, Astrid Yang, Junkai Matthews, Jason D Ghosn, Eliver Kugathasan, Subra Qiu, Peng Inflamm Bowel Dis Basic Science Research BACKGROUND: Crohn’s disease is a lifelong disease characterized by chronic inflammation of the gastrointestinal tract. Defining the cellular and transcriptional composition of the mucosa at different stages of disease progression is needed for personalized therapy in Crohn’s. METHODS: Ileal biopsies were obtained from (1) control subjects (n = 6), (2) treatment-naïve patients (n = 7), and (3) established (n = 14) Crohn’s patients along with remission (n = 3) and refractory (n = 11) treatment groups. The biopsies processed using 10x Genomics single cell 5' yielded 139 906 cells. Gene expression count matrices of all samples were analyzed by reciprocal principal component integration, followed by clustering analysis. Manual annotations of the clusters were performed using canonical gene markers. Cell type proportions, differential expression analysis, and gene ontology enrichment were carried out for each cell type. RESULTS: We identified 3 cellular compartments with 9 epithelial, 1 stromal, and 5 immune cell subtypes. We observed differences in the cellular composition between control, treatment-naïve, and established groups, with the significant changes in the epithelial subtypes of the treatment-naïve patients, including microfold, tuft, goblet, enterocyte,s and BEST4+ cells. Surprisingly, fewer changes in the composition of the immune compartment were observed; however, gene expression in the epithelial and immune compartment was different between Crohn’s phenotypes, indicating changes in cellular activity. CONCLUSIONS: Our study identified cellular and transcriptional signatures associated with treatment-naïve Crohn’s disease that collectively point to dysfunction of the intestinal barrier with an increase in inflammatory cellular activity. Our analysis also highlights the heterogeneity among patients within the same disease phenotype, shining a new light on personalized treatment responses and strategies. Oxford University Press 2022-10-07 /pmc/articles/PMC9890215/ /pubmed/36206201 http://dx.doi.org/10.1093/ibd/izac201 Text en © 2022 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Basic Science Research
Maddipatla, Sushma Chowdary
Kolachala, Vasantha L
Venkateswaran, Suresh
Dodd, Anne F
Pelia, Ranjit Singh
Geem, Duke
Yin, Hong
Sun, Yutong
Xu, Congmin
Mo, Angela
Kosters, Astrid
Yang, Junkai
Matthews, Jason D
Ghosn, Eliver
Kugathasan, Subra
Qiu, Peng
Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
title Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
title_full Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
title_fullStr Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
title_full_unstemmed Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
title_short Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
title_sort assessing cellular and transcriptional diversity of ileal mucosa among treatment-naïve and treated crohn’s disease
topic Basic Science Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890215/
https://www.ncbi.nlm.nih.gov/pubmed/36206201
http://dx.doi.org/10.1093/ibd/izac201
work_keys_str_mv AT maddipatlasushmachowdary assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT kolachalavasanthal assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT venkateswaransuresh assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT doddannef assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT peliaranjitsingh assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT geemduke assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT yinhong assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT sunyutong assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT xucongmin assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT moangela assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT kostersastrid assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT yangjunkai assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT matthewsjasond assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT ghosneliver assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT kugathasansubra assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease
AT qiupeng assessingcellularandtranscriptionaldiversityofilealmucosaamongtreatmentnaiveandtreatedcrohnsdisease